Glucocorticoid sparing effect of Janus kinase inhibitors compared to biologic disease modifying anti-rheumatic drugs in rheumatoid arthritis, a single-centre retrospective analysis
Our findings indicate that JAKi facilitate more rapid glucocorticoid tapering compared with bDMARDs in RA patients. These results underscore the potential of JAKi to reduce long-term glucocorticoid exposure, highlighting their value in RA management strategies, including minimizing glucocorticoid-related adverse effects.
Authors
- Ombretta Viapiana (ORCID: https://orcid.org/0000-0003-1917-5655)
- Andrea Morciano (ORCID: https://orcid.org/0000-0001-5420-4277)
- Maurizio Rossini (ORCID: https://orcid.org/0000-0001-9692-2293)
- Davide Gatti (ORCID: https://orcid.org/0000-0002-7471-3076)
- Francesca Mastropaolo (ORCID: https://orcid.org/0000-0002-3225-2152)
- Valeria Messina (ORCID: https://orcid.org/0000-0003-0397-4428)
- Antonio Carletto (ORCID: https://orcid.org/0000-0002-3350-4438)
- Giovanni Adami (ORCID: https://orcid.org/0000-0002-8915-0755)
- Isotta Galvagni
- Riccardo Bixio (ORCID: https://orcid.org/0000-0001-9335-3371)
- Elena Fracassi (ORCID: https://orcid.org/0000-0003-1354-8115)
- Giulia Virelli
- Francesca Ruzzon
Institutions
- University of Verona (IT)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1093/rheumatology/keae455
- Citations
- 5
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 2.35